Content area

Abstract

Translate

Dobesilate is an anti-inflammatory and antipermeability agent. Intravitreal administration of this compound is a therapeutically beneficial agent in the treatment of chronic cystoid macular oedema.

Details

Subject
Cataracts;
Tomography;
Diabetes;
Vascular endothelial growth factor;
Fibroblasts;
Eye surgery;
Retina;
Permeability;
Steroids;
Cytokines;
Edema;
Side effects;
Inflammation;
Case reports;
Anti-inflammatory agents;
Visual acuity;
Angiogenesis
Title
Chronic cystoid macular oedema treated with intravitreal dobesilate
Author
Cuevas, Pedro 1 ; Outeiriño, Luis A 2 ; Angulo, Javier 1 ; Giménez-Gallego, Guillermo 3 

1  Department of Research, Hospital Ramon y Cajal, Madrid, Spain 
2  Department of Ophthalmology, Hospital de Día Pio XII, Madrid, Spain 
3  Department of Qiimica de Proteinas, Centro de Investigaciones Biológicas, Madrid, Spain 
Publication title
BMJ Case Reports; London
Volume
2012
First page
bcr2012006376
Number of pages
4
Publication year
2025
Publication date
Sep 2025
Publisher
BMJ Publishing Group LTD
Place of publication
London
Country of publication
United Kingdom
Publication subject
Medical Sciences
e-ISSN
1757790X
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article, Case Study
Publication history
 
 
Online publication date
2025-09-22
Publication history
 
 
   First posting date
22 Sep 2025
DOI
https://doi.org/10.1136/bcr-2012-006376
ProQuest document ID
3253090011
Document URL
https://www.proquest.com/scholarly-journals/chronic-cystoid-macular-oedema-treated-with/docview/3253090011/se-2?accountid=208611
Copyright
Copyright BMJ Publishing Group LTD 2025
Last updated
2025-10-06
Database
ProQuest One Academic